Wen‐Yen Chiou

924 total citations
60 papers, 667 citations indexed

About

Wen‐Yen Chiou is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Wen‐Yen Chiou has authored 60 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Wen‐Yen Chiou's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Head and Neck Cancer Studies (8 papers) and Advanced Radiotherapy Techniques (6 papers). Wen‐Yen Chiou is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Head and Neck Cancer Studies (8 papers) and Advanced Radiotherapy Techniques (6 papers). Wen‐Yen Chiou collaborates with scholars based in Taiwan, United States and Germany. Wen‐Yen Chiou's co-authors include Shih‐Kai Hung, Hon‐Yi Lin, Yu‐Chieh Su, Moon‐Sing Lee, Liang‐Cheng Chen, Hsu-Chueh Ho, Moon-Sing Lee, Ching‐Chih Lee, Hsien‐Bin Huang and Chun‐Ming Chang and has published in prestigious journals such as PLoS ONE, Cancer and Stroke.

In The Last Decade

Wen‐Yen Chiou

57 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Yen Chiou Taiwan 16 158 156 156 126 123 60 667
Ayşe Kars Türkiye 16 187 1.2× 254 1.6× 73 0.5× 83 0.7× 90 0.7× 73 773
Arben Lleshi Italy 18 108 0.7× 420 2.7× 161 1.0× 125 1.0× 74 0.6× 49 880
Deniz Tural Türkiye 17 377 2.4× 478 3.1× 89 0.6× 217 1.7× 116 0.9× 121 938
Ravi Kumar Paluri United States 15 140 0.9× 326 2.1× 70 0.4× 117 0.9× 112 0.9× 64 684
Cindy Lim Singapore 15 119 0.8× 167 1.1× 56 0.4× 176 1.4× 109 0.9× 36 560
Nazım Serdar Turhal Türkiye 15 311 2.0× 369 2.4× 128 0.8× 181 1.4× 99 0.8× 69 800
S. Harrison United States 20 537 3.4× 279 1.8× 238 1.5× 296 2.3× 86 0.7× 90 984
Hemant Malhotra India 17 168 1.1× 239 1.5× 54 0.3× 76 0.6× 100 0.8× 72 973
Liucheng Wu China 15 215 1.4× 173 1.1× 73 0.5× 232 1.8× 106 0.9× 30 666
Özgür Özyılkan Türkiye 15 309 2.0× 431 2.8× 109 0.7× 166 1.3× 76 0.6× 115 792

Countries citing papers authored by Wen‐Yen Chiou

Since Specialization
Citations

This map shows the geographic impact of Wen‐Yen Chiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Yen Chiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Yen Chiou more than expected).

Fields of papers citing papers by Wen‐Yen Chiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Yen Chiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Yen Chiou. The network helps show where Wen‐Yen Chiou may publish in the future.

Co-authorship network of co-authors of Wen‐Yen Chiou

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Yen Chiou. A scholar is included among the top collaborators of Wen‐Yen Chiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Yen Chiou. Wen‐Yen Chiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Hon‐Yi, Michael W.Y. Chan, Shu‐Fen Wu, et al.. (2024). Olaparib enhancing radiosensitization and anti-metastatic effect of oral cancer by targeting IL-17A signal. Cancer Cell International. 24(1). 373–373. 3 indexed citations
2.
Chiou, Wen‐Yen, et al.. (2024). Proton Pump Inhibitors Worsen Colorectal Cancer Outcomes in Patients Treated with Bevacizumab. Cancers. 16(19). 3378–3378.
3.
Chen, Liang‐Cheng, Moon‐Sing Lee, Hon‐Yi Lin, et al.. (2024). Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study. PLoS ONE. 19(3). e0300391–e0300391. 1 indexed citations
4.
Hung, Shih‐Kai, et al.. (2024). Dosimetry and efficiency comparison of knowledge-based and manual planning using volumetric modulated arc therapy for craniospinal irradiation. Radiology and Oncology. 58(2). 289–299. 2 indexed citations
5.
6.
Lin, Hon‐Yi, Chen-Hsi Hsieh, Michael W.Y. Chan, et al.. (2023). IRAK2, an Immune and Radiation-Response Gene, Correlates with Advanced Disease Features but Predicts Higher Post-Irradiation Local Control in Non-Metastatic and Resected Oral Cancer Patients. International Journal of Molecular Sciences. 24(8). 6903–6903. 3 indexed citations
7.
Chen, Yen‐Chun, Yen‐Chun Chen, Yida Li, et al.. (2022). No dose-response relationship of clarithromycin utilization on cardiovascular outcomes in patients with stable coronary heart disease: Analysis of Taiwan’s national health insurance claims data. Frontiers in Cardiovascular Medicine. 9. 1018194–1018194. 3 indexed citations
8.
Hung, Shih‐Kai, et al.. (2022). Impact of Hypertensive Disorders of Pregnancy on the Risk of Stroke Stratified by Subtypes and Follow-Up Time. Stroke. 53(2). 338–344. 25 indexed citations
9.
Chen, Yi‐Chun, et al.. (2022). Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. Journal of Clinical Medicine. 11(19). 5612–5612. 8 indexed citations
10.
Chan, Michael W.Y., Hon‐Yi Lin, Wen‐Yen Chiou, et al.. (2021). IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell Carcinoma. Frontiers in Oncology. 11. 647175–647175. 9 indexed citations
11.
Chiou, Wen‐Yen, Shih‐Kai Hung, Kuo‐Chih Tseng, et al.. (2019). Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion. Tzu Chi Medical Journal. 31(1). 40–40. 6 indexed citations
12.
Fu, Shu‐Ling, et al.. (2018). Andrographolide enhances the anti-metastatic effect of radiation in Ras-transformed cells via suppression of ERK–mediated MMP-2 activity. PLoS ONE. 13(10). e0205666–e0205666. 19 indexed citations
13.
14.
Hung, Shih‐Kai, Yi‐Chun Chen, Wen‐Yen Chiou, et al.. (2017). Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a population-based surgical cohort study. BMJ Open. 7(9). e015022–e015022. 2 indexed citations
15.
Wei, Kai‐Che, Hon‐Yi Lin, Shih‐Kai Hung, et al.. (2016). Leukemia Risk After Cardiac Fluoroscopic Interventions Stratified by Procedure Number, Exposure Latent Time, and Sex. Medicine. 95(10). e2953–e2953. 9 indexed citations
16.
17.
Chiou, Wen‐Yen, Shih‐Kai Hung, Chun‐Liang Lai, et al.. (2015). Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization. Medicine. 94(26). e1022–e1022. 22 indexed citations
18.
Su, Yu‐Chieh, Fei‐Ting Hsu, Shu‐Ling Fu, et al.. (2014). Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway. International Journal of Molecular Medicine. 34(5). 1417–1422. 10 indexed citations
19.
20.
Hsu, Ta-Wen, Wen‐Yao Yin, Chun‐Ming Chang, et al.. (2013). Prognostic factors affecting short-term outcome of curative rectal cancer resection. Tzu Chi Medical Journal. 25(1). 47–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşe Kars Breakdown of academic impact, for papers by Arben Lleshi Breakdown of academic impact, for papers by Deniz Tural Breakdown of academic impact, for papers by Ravi Kumar Paluri Breakdown of academic impact, for papers by Cindy Lim Breakdown of academic impact, for papers by Nazım Serdar Turhal Breakdown of academic impact, for papers by S. Harrison Breakdown of academic impact, for papers by Hemant Malhotra Breakdown of academic impact, for papers by Liucheng Wu Breakdown of academic impact, for papers by Özgür Özyılkan
Rankless by CCL
2026